Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.99 USD | -1.60% | -2.72% | +25.34% |
May. 13 | Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MYRIAD GENETICS, INC. | Diagnostic & Testing Substances | -1.60% | -2.72% | +25.34% | +19.53% | -3.31% | 2.17B |
Technical Rankings Surperformance
- Stock Market
- Equities
- MYGN Stock
- Charts Myriad Genetics, Inc.
- Comparison Chart